By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZIOPHARM Oncology, Inc. 

1180 Avenue of the Americas
19th Floor
New York  New York  10036  U.S.A.
Phone: 646-214-0700 Fax: 646-214-0711


Company News
ZIOPHARM Oncology (ZIOP) To Host First-Quarter 2017 Financial Results And Corporate Update Conference Call On May 1, 2017 At 4:30 P.M. ET 4/24/2017 11:33:55 AM
ZIOPHARM Oncology (ZIOP) Release: Biopharma And Intrexon (XON) Announce Cooperative Research And Development Agreement With The NCI Utilizing Sleeping Beauty System To Generate T Cells Targeting Neoantigens 1/10/2017 10:42:37 AM
ZIOPHARM Oncology (ZIOP) Falls Some More After Experimental Gene Therapy is Tied to 'Higher Than Expected' Toxicity 10/10/2016 7:49:25 AM
4 Movers & Shakers in This Year’s Oncology Market 6/15/2016 6:48:59 AM
Journalist Criticizes ZIOPHARM Oncology (ZIOP.OB) as Its Own ‘Biotech Bubble’ Held Aloft by Ties to R.J. Kirk's Intrexon (XON) 5/20/2016 5:59:59 AM
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/5/2016 6:29:13 AM
ZIOPHARM Oncology (ZIOP.OB) To Host Corporate Update And 2016 Outlook Conference Call On Wednesday, December 16, 2015 At 4:30 PM ET 12/11/2015 7:33:02 AM
ZIOPHARM Oncology (ZIOP.OB) Announces Presentation Of Phase Ib/II Study Of Ad-RTS-Hil-12 Gene Therapy In Patients With Locally Advanced Or Metastatic Breast Cancer At 2015 SABCS 12/10/2015 7:16:03 AM
ZIOPHARM Oncology (ZIOP.OB) Announces Presentation Of Data From CD19-Specific CAR+ T-Cell Therapy Programs At American Society of Hematology Annual Meeting 12/8/2015 9:52:36 AM
ZIOPHARM Oncology (ZIOP.OB) Announces Data Highlighting Ad-RTS-Hil-12 Activity In Glioma At SNO 11/19/2015 7:57:36 AM